ABIONYX Pharma vs Infinimmune

ABIONYX Pharma vs Infinimmune, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ABIONYX Pharma is on 44/100 and Infinimmune on 60/100.

ABIONYX Pharma logo
ABIONYX PharmaBiopharmaceutical company developing innovative therapies for sepsis and intensive care.
Try ABIONYX Pharma
Infinimmune logo
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Try Infinimmune

Where each one leads

ABIONYX Pharma

  • domain rating: 25/100 against 20/100
  • funding raised: $225M against $75.0M

Infinimmune

  • our overall score: 60/100 against 44/100

At a glance

MeasureABIONYX PharmaInfinimmune
What it isBiopharmaceutical company developing innovative therapies for sepsis and intensive care.Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CategoryBiotechnology, Pharmaceuticals, Healthcare, BiotechBiotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech
Sells toBusiness modelB2BB2B
OfferingServicesPlatform
Founded20152017
HeadquartersToulouse, FranceAlameda, United States
StatusActiveActive

Size, funding and growth

MeasureABIONYX PharmaInfinimmune
EmployeesNot published22
Total funding$225M$75.0M
Latest roundCapital IncreaseSeries A
Valuation$1.1BNot published
LinkedIn followersNot published4,055

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureABIONYX PharmaInfinimmune
StartupHub scoreOur 0-100 rating44/10060/100
Traction40/10053/100
Team20/10070/100
Search visibility5/10023/100
Quality58/10068/100
Agent readinessHow well an AI agent can read and act on the siteD (43/100)D (42/100)
Domain ratingLink authority, 0-10025/10020/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureABIONYX PharmaInfinimmune
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSNot detectedWebflow
FrameworksJqueryNot detected
AnalyticsGoogle Analytics 4Google Analytics 4

ABIONYX Pharma vs Infinimmune: common questions

Which is better, ABIONYX Pharma or Infinimmune?

On our 0-100 score Infinimmune rates higher (60/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.

How do ABIONYX Pharma and Infinimmune compare on the numbers?

ABIONYX Pharma leads on domain rating (25/100 against 20/100), funding raised ($225M against $75.0M). Infinimmune leads on our overall score (60/100 against 44/100).

Read the full ABIONYX Pharma review and pricing or the Infinimmune review and pricing. You can also browse other ABIONYX Pharma alternatives we track.